Regulation of inhibin β chains and follistatin mRNA levels during rat hepatocyte growth induced by the peroxisome proliferator di-n-butyl phthalate

被引:8
作者
Kobayashi, T
Niimi, S
Fukuoka, M
Hayakawa, T
机构
[1] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan
[2] Showa Pharmaceut Univ, Dept Clin Pharmacol & Toxicol, Tokyo 1948543, Japan
关键词
inhibin beta chain; follistatin; peroxisome proliferator; hepatocyte growth;
D O I
10.1248/bpb.25.1214
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators stimulate hepatocyte growth in rat liver in vivo. Activin A, a homodimer of inhibin beta(A), inhibits DNA synthesis in hepatocytes. The inhibitory action of activin A is suppressed by follistatin, an activin-binding protein. In this paper, we investigated whether administration of di-n-butyl phthalate (DBP), a peroxisome proliferator, modifies the production of activin A and follistatin in rat liver by hourly monitoring of inhibin beta(A) and follistatin mRNA levels by reverse transcriptase polymerase chain reaction analysis. The mRNA levels of the other inhibin beta chains (inhibin beta(B) and beta(C)) were examined in a similar manner. The inhibin beta(A) mRNA level decreased to about 30% by 3 h after DBP administration (8.6 mmol/kg body weight), remained low until 12 h, and returned to its original level by 24 h. The follistatin mRNA level increased to about 2 times by 6 h, and returned to its original level by 24 h. The inhibin beta(B) mRNA had started to increase by 1 h, peaked at 6 It at about 4 times its initial level, and returned to its original level by 12 h. The inhibin beta(C) mRNA level had doubled by 6 h and it returned to its original level. These results indicate that the growth stimulatory action of peroxisome proliferators may be mediated via the decrease in activin A level and activity and suggest that the increases in follistatin as well as inhibin beta(B) and beta(C) chains may play a role in peroxisome proliferator-stimulated hepatocyte growth.
引用
收藏
页码:1214 / 1216
页数:3
相关论文
共 23 条
[1]   Liver regeneration .8. Liver regeneration versus direct hyperplasia [J].
Columbano, A ;
Shinozuka, H .
FASEB JOURNAL, 1996, 10 (10) :1118-1128
[2]   The rodent non-genotoxic hepatocarcinogen nafenopin suppresses apoptosis preferentially in non-cycling hepatocytes but also elevates CDK4, a cell cycle progression factor [J].
Gill, JH ;
Brickell, P ;
Dive, C ;
Roberts, RA .
CARCINOGENESIS, 1998, 19 (10) :1743-1747
[3]   Levels of transforming growth factor β and transforming growth factor β receptors in rat liver during growth, regression by apoptosis and neoplasia [J].
Grasl-Kraupp, B ;
Rossmanith, W ;
Ruttkay-Nedecky, B ;
Müllauer, L ;
Kammerer, B ;
Bursch, W ;
Schulte-Hermann, R .
HEPATOLOGY, 1998, 28 (03) :717-726
[4]  
KAWASHIMA Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P259
[5]  
Kobayashi T, 2000, BIOL PHARM BULL, V23, P755
[6]  
Kren BT, 1997, ANN NY ACAD SCI, V831, P361
[7]   PITUITARY FSH IS RELEASED BY A HETERODIMER OF THE BETA-SUBUNITS FROM THE 2 FORMS OF INHIBIN [J].
LING, N ;
YING, SY ;
UENO, N ;
SHIMASAKI, S ;
ESCH, F ;
HOTTA, M ;
GUILLEMIN, R .
NATURE, 1986, 321 (6072) :779-782
[8]  
MASUHARA M, 1992, HEPATOLOGY, V16, P1241, DOI 10.1016/0270-9139(92)90021-Z
[9]   Localization of activin ßA-, ßB-, and ßC-subunits in human prostate and evidence for formation of new activin heterodimers of ßC-subunit [J].
Mellor, SL ;
Cranfield, M ;
Ries, R ;
Pedersen, J ;
Cancilla, B ;
de Kretser, D ;
Groome, NP ;
Mason, AJ ;
Risbridger, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4851-4858
[10]   LIVER-REGENERATION - MOLECULAR MECHANISMS OF GROWTH-CONTROL [J].
MICHALOPOULOS, GK .
FASEB JOURNAL, 1990, 4 (02) :176-187